# Guidance for Industry for the Evaluation of Combination Vaccines for Preventable Diseases: Production, Testing and Clinical Studies:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/guidance-for-industry-for-the-evaluation-of-combination-vaccines-for-preventable-diseases-production-testing-and-clinical-studies-guidance-for-industry/c4cd1aec-70c4-4a85-a37c-f9b90e15c425

> FDA guidance document: Guidance for Industry for the Evaluation of Combination Vaccines for Preventable Diseases: Production, Testing and Clinical Studies:  Guidance for Industry. Issue date: April 10, 1997. Get complete insights and analysis.

---

## Details

- Title: Guidance for Industry for the Evaluation of Combination Vaccines for Preventable Diseases: Production, Testing and Clinical Studies:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 1997-04-10
- Last Changed: 2024-07-26
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1997-N-0454">FDA-1997-N-0454</a>

## Related Documents

- [CVM GFI #268 Adaptive and Other Innovative Designs for Effectiveness Studies of New Animal Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-268-adaptive-and-other-innovative-designs-for-effectiveness-studies-of-new-animal-drugs/aec0e84d-2ef0-4428-b0c0-3cb5a94073b5)
- [CVM GFI #267 Biomarkers and Surrogate Endpoints in Clinical Studies to Support Effectiveness of New Animal Drugs](https://www.globalkeysolutions.net/guidances/guidance-document/cvm-gfi-267-biomarkers-and-surrogate-endpoints-in-clinical-studies-to-support-effectiveness-of-new-animal-drugs/017aa044-c960-4f4a-b6e9-4aed194af7c4)
- [Proposed Approach to Regulation of Cellular and Tissue-Based Products](https://www.globalkeysolutions.net/guidances/guidance-document/proposed-approach-to-regulation-of-cellular-and-tissue-based-products/d4c69ac2-d93b-4834-9b6f-c6a4c0387ab9)